MULTIPLE MYELOMA
Latest News
November 20th 2024
During a Case-Based Roundtable® event, Omar Nadeem, MD, and participants reacted to data from the MonumenTAL-1 trial in the first article of a 2-part series.
More News
DREAMM-2 Results Move Belantamab Mafodotin Forward in the Treatment of Multiple Myeloma
December 18th 2019Results of the phase II DREAMM-2 trial recently published in The Lancet Oncology showed that the investigational agent belantamab mafodotin induced response rates above 30% and had a manageable safety profile in patients with heavily pretreated multiple myeloma.
Read More
Vij Highlights Benefits of Quadruplet Therapy for Patients With Multiple Myeloma
December 14th 2019During a Targeted Oncology™ case-based peer perspectives live discussion, Ravi Vij, MD, MBA, professor, Department of Medicine, Oncology Division, Bone Marrow Tranplantation & Leukemia, Washington University School of Medicine in St. Louis spoke with a group of oncologists about best practices for treating patients with multiple myeloma. The ideas he presented were based on a real case of a male patient with multiple myeloma.
Read More
